Фармакоэкономика (Apr 2022)

Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate

  • I. Yu. Torshin,
  • T. B. Minasov,
  • N. V. Zagorodniy,
  • A. M. Lila,
  • O. A. Gromova

DOI
https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.136
Journal volume & issue
Vol. 15, no. 1
pp. 162 – 169

Abstract

Read online

Joint endoprosthetics is a treatment of choice for patients with decompensated osteoarthritis (OA), who have exhausted the possibilities of pharmacotherapy and other methods of conservative treatment. Preparation for endoprosthetics and rehabilitation after surgery usually includes measures to improve the muscle condition and local blood circulation in the joint area, and if necessary, pain management. The unique spectrum of anti-inflammatory effect of chondroprotectors based on chondroitin sulfate and glucosamine sulfate includes inhibition of NF-κB cascade, toll-like receptors, pro-inflammatory cytokines, metalloproteinases, and significantly alleviates the course of OA. Reducing the severity of OA is important for preparing for surgery, subsequent rehabilitation, and preventing the revision surgery.

Keywords